リボソームアシル転送部位に結合する新種の抗生物質の設計
Jalal Haddad1, Lakshmi P Kotra, Beatriz Llano-Sotelo
1Department of Chemistry, Institute for Drug Design, Wayne State University, Detroit, MI 48202, USA.
Journal of the American Chemical Society
|March 28, 2002
まとめ
バクテリアのリボソームRNAを標的とした新しい設計抗生物質が合成され,病原体に対する活性が強化されました. これらの新しい化合物は,既存のアミノグリコシド耐性メカニズムを克服し,有望な新種の抗菌剤を提供する.
科学分野:
- 薬用化学 薬用化学について
- 分子生物学は分子生物学である.
- バクテリアの遺伝学
背景:
- アミノグリコシド抗生物質は,細菌感染症の治療に不可欠です.
- 抗生物質の耐性,特にアミノグリコシドに対する耐性は,世界的な健康上の脅威として増大しています.
- アミノグリコシド-リボソームRNA相互作用の構造的基礎を理解することは,新薬の設計の鍵です.
研究 の 目的:
- 改善された抗菌活性を持つ新しいアミノグリコシド化合物の設計と合成.
- バクテリアの既存のアミノグリコシド耐性メカニズムを克服するために.
- 新しい抗生物質の開発のための構造ベースの薬剤設計原理を探求する.
主な方法:
- バクテリアのリボソームRNA (rRNA) Aサイトに結合したネアミンの結晶構造を利用した.
- rRNA結合ポケットに適合する化合物の化学データベースの大規模な計算検索を行った.
- 7つの新しい化合物を合成し,AサイトrRNAへの結合親和性を評価した.
- 病原性細菌と耐性酵素に対する抗菌活性がインビトロおよびインビボで評価されています.
主要な成果:
- 合成された7つの化合物はすべて,ネアミンのようにA部位rRNAに類似した結合を示した.
- 新型設計抗生物質は,様々な病原体に対する抗菌活性が著しく強化されたことを示した.
- これらの化合物は,高レベルのアミノグリコシド耐性を持つ細菌に対して高い有効性を示しました.
- 実験室内および体内での実験では,合成化合物が重要なアミノグリコシド耐性酵素の弱い基質であることを確認しました.
結論:
- 構造に基づく設計アプローチにより,強力な抗菌作用を持つ新しいアミノグリコシドが得られました.
- 設計された化合物は,一般的なアミノグリコシド耐性機構を効果的に回避します.
- この戦略は,耐性細菌感染症と戦うために次世代の抗生物質を開発するための有望な経路を提供します.
関連する概念動画
01:27Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
01:16Transduction
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome are...
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...